Red Light Holland Announces New Filament Health PEX010 European Research Shipment
Toronto, Ontario--(Newsfile Corp. - July 16, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded its pharmaceutical grade manufacturing, regulatory, and clinical research capabilities, supporting the advancement of naturally derived
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-07-16 8:03 AM EDT | Red Light Holland Corp.
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website. The redesigned website is now live, with the project still in progress and active changes and improvements currently being made.
Healthcare and Hospitals, Health
2026-07-15 9:30 AM EDT | Adia Med Inc.
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces it has closed its previously announced inaugural private placement offering (the "Offering") of $150 million aggregate principal amount of 6.875% senior u
Technology, Computer Software, Healthcare and Hospitals, Health
2026-07-15 9:00 AM EDT | WELL Health Technologies Corp.
HarmonyRx Highlights 22 Years of Pharmacy Benefits Expertise, Building on Foundation as Broadreach Medical Research (BMR)
New York, New York--(Newsfile Corp. - July 15, 2026) - Since its founding as Broadreach Medical Research (BMR) in 2004, HarmonyRx has remained committed to transparency, clinical expertise and helping employers optimize pharmacy benefits. With more than two decades of experience in pharmacy benefits, HarmonyRx has grown alongside a rapidly changing healthcare landscape. As pharmacy costs have increased and benefit models have become more complex, the organization has remained focused on
2026-07-15 8:15 AM EDT | HarmonyRx
Extendicare Announces July 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - July 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare
Healthcare and Hospitals, Pharmaceuticals, Health
2026-07-15 8:00 AM EDT | Extendicare Inc.
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 15, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that the Israel Innovation Authority (IIA) has approved a 4.33 million NIS (approximately USD $1.4 million) grant. This non-dilutive funding will support a new research initiative at BioHar
Biotechnology, Pharmaceuticals, Health
2026-07-15 7:30 AM EDT | BioHarvest Sciences Inc.
Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products
Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that the State of Texas has approved the Company's license to manufacture and distribute consumable hemp products. This approval turns years of vision, science, and preparation into action and marks the moment CBIH steps into the market and begins commercial distribution. The Company e
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-07-15 7:00 AM EDT | Cannabis Bioscience International Holdings
Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
King of Prussia, Pennsylvania--(Newsfile Corp. - July 15, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today significant progress in the protection of its proprietary innovations across key international markets. The company has received multiple favorable patent actions encompassing three
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-07-15 7:00 AM EDT | Phio Pharmaceuticals Corp.
LevelJump Announces 2026 Q1 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the quarter ended March 31, 2026. Financial and Operational Highlights Revenues were $4.7 million in the first quarter of 2026 compared to $4.58 million in revenues for the first quarter of 2025, a year over year revenue increase of 2.7%. Canadian Teleradiology Se
Healthcare and Hospitals, Health
2026-07-14 7:00 PM EDT | LevelJump Healthcare Corp.
LevelJump Announces 2025 Financial Results
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2025. Financial and Operational Highlights Revenues were $19.1 million in 2025 compared to $17.7 million in revenues for 2024, a year over year revenue increase of 7.9%. Canadian T
Healthcare and Hospitals, Health
2026-07-14 6:30 PM EDT | LevelJump Healthcare Corp.
AAMI Updates Standard for Manufacturers of Medtech Steam Sterilization Systems
Arlington, Virginia--(Newsfile Corp. - July 14, 2026) - The Association for the Advancement of Medical Instrumentation (AAMI) today announces the revision to its American National Standard that establishes safety and performance requirements for steam sterilization units used to process reusable medical devices in hospitals and other healthcare delivery organizations.
2026-07-14 8:55 AM EDT | Association for the Advancement of Medical Instrumentation
QScreen AI Secures Second US Patent, Extending Single-Camera Impairment Detection on Standard Hardware
Toronto, Ontario--(Newsfile Corp. - July 14, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or the "Company") now holds two granted US patents covering its core impairment-detection method, after the United States Patent and Trademark Office granted the Company US Patent No. 12,640,164, "Systems and Methods for Detecting Impairment of an Individual," on May 26, 2026. The new grant extends the Company's protection to impairment detection from a single came
2026-07-14 7:02 AM EDT | QScreen AI Inc.
TelyRx Expands Operations in Clearwater, Fla., Tripling Footprint to Meet Growing Demand for Digital Healthcare
Clearwater, Florida--(Newsfile Corp. - July 14, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a digital healthcare and online pharmacy platform, today announced a major expansion of its Clearwater headquarters and pharmacy operations, following the milestone of one million prescriptions filled and first-quarter revenue growth of 180% year-over-year. The move more than triples TelyRx's overall footprint to meet growing consumer
Healthcare and Hospitals, Health
2026-07-14 7:00 AM EDT | TelyRx
Restart Life Sciences Leverages University of Manitoba RCFTR Collaboration for Pre-Production Transition of New Protein Frameworks
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide a strategic operational update regarding its collaboration with the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. Following the recent unveiling of its newly formulated product roadmap, targeted to capitalize on emerging consumer shopping patterns, the Comp
Technology, Biotechnology, Health
2026-07-14 6:00 AM EDT | Restart Life Sciences Corp.
Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ
Winter Park, Florida--(Newsfile Corp. - July 13, 2026) - Adia Med Inc. (OTCQB: ADIA) (formerly Adia Nutrition Inc.), focused on regenerative medicine, stem cell therapies, and biologics, today highlighted its rapid advancement and major milestones achieved since the January 2024 leadership transition.
Healthcare and Hospitals, Health
2026-07-13 9:00 AM EDT | Adia Med Inc.
BetterLife Pharma Prioritizes BETR-001 to Lead in Migraine and Headache Disorders, Targeting a Clinically Validated, FDA-Precedented Serotonergic Mechanism
Vancouver, British Columbia--(Newsfile Corp. - July 13, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company"), today announced the prioritization of its lead clinical-stage asset, BETR-001, to pursue migraine and other primary headache disorders as its lead indications. The strategic focus concentrates BETR-001's development on one of the largest, most disabling and most underserved areas of neurology, and does so through a serotonin-receptor me
2026-07-13 8:00 AM EDT | BetterLife Pharma Inc.
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
British Columbia and Rehovot, Israel--(Newsfile Corp. - July 13, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held virtually on July 22, 2026.
Biotechnology, Pharmaceuticals, Health
2026-07-13 8:00 AM EDT | BioHarvest Sciences Inc.
Glow Lifetech Advances National Expansion Strategy with Quebec Commercial Partnership
Toronto, Ontario--(Newsfile Corp. - July 13, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce it has entered into an exclusive Quebec sales, distribution and licensing agreement with Les Cultures Seaweed Gaspésie Inc. ("Seaweed Cannabis"), establishing the commercial infrastructure to support the commercialization of Glow's MOD™ and .decimal™ brands in Quebec. The partnership represents another im
2026-07-13 7:30 AM EDT | Glow Lifetech Corp.
Rejuvenate Muscle Health(TM) Expands its Position in the Emerging GLP-1 Muscle Health Category with U.S. Pharmacy Program and National E-Commerce Expansion
Burlington, Ontario--(Newsfile Corp. - July 13, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company") a muscle health company with distributi
Food / Beverages, Sports, Health
2026-07-13 7:00 AM EDT | Promino Nutritional Sciences, Inc.
WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering
WELL has priced its inaugural offering of $150 million of senior unsecured notes due 2031, bearing interest at 6.875% per annum. Net proceeds will be used to fully repay WELL's convertible debentures due December 2026 and for general corporate purposes. The Offering extends WELL's debt maturity profile to 2031 and strengthens the Company's balance sheet to support continued growth in Canada. All amounts in
Technology, Computer Software, Healthcare and Hospitals, Health
2026-07-13 6:30 AM EDT | WELL Health Technologies Corp.